Login / Signup

Bispecific T cell engagers targeting CD20/CD3 in B-cell lymphoma: latest updates from 2023 EHA annual meeting.

Shenhe JinYi LiuYe ZhangFengping ZhouLiang-Shun YouJin Zhang
Published in: Therapeutic advances in chronic disease (2023)
Keyphrases
  • diffuse large b cell lymphoma
  • cancer therapy